Cigna Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Cigna Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$344K	Hold	20,542	–	–	0.06%	311
2025 Q1	$315K	Hold	20,542	–	–	0.06%	318
2024 Q4	$452K	Hold	20,542	–	–	0.08%	241
2024 Q3	$370K	Buy	20,542 +82	+0.4%	+$1.48K	0.07%	297
2024 Q2	$332K	Buy	20,460 +143	+0.7%	+$2.32K	0.06%	309
2024 Q1	$286K	Sell	20,317 -474	-2%	-$6.67K	0.05%	348
2023 Q4	$217K	Hold	20,791	–	–	0.04%	401
2023 Q3	$212K	Hold	20,791	–	–	0.05%	387
2023 Q2	$157K	Hold	20,791	–	–	0.03%	445
2023 Q1	$184K	Sell	20,791 -1,405	-6%	-$12.4K	0.04%	438
2022 Q4	$203K	Buy	22,196 +28	+0.1%	+$256	0.04%	432
2022 Q3	$179K	Buy	22,168 +593	+3%	+$4.79K	0.04%	416
2022 Q2	$163K	Buy	21,575 +1,024	+5%	+$7.74K	0.03%	443
2022 Q1	$193K	Buy	20,551 +4,144	+25%	+$38.9K	0.02%	577
2021 Q4	$131K	Hold	16,407	–	–	0.01%	641
2021 Q3	$160K	Hold	16,407	–	–	0.01%	720
2021 Q2	$162K	Hold	16,407	–	–	0.01%	735
2021 Q1	$189K	Hold	16,407	–	–	0.01%	747
2020 Q4	$159K	Buy	16,407 +763	+5%	+$7.39K	0.01%	710
2020 Q3	$141K	Sell	15,644 -930	-6%	-$8.38K	0.01%	609
2020 Q2	$204K	Sell	16,574 -3,776	-19%	-$46.5K	0.02%	680
2020 Q1	$183K	Hold	20,350	–	–	0.02%	562
2019 Q4	$212K	Buy	20,350 +970	+5%	+$10.1K	0.02%	608
2019 Q3	$158K	Hold	19,380	–	–	0.02%	642
2019 Q2	$154K	Buy	19,380 +1,841	+10%	+$14.6K	0.02%	644
2019 Q1	$275K	Buy	17,539 +197	+1%	+$3.09K	0.03%	556
2018 Q4	$267K	Buy	17,342 +959	+6%	+$14.8K	0.02%	569
2018 Q3	$328K	Hold	16,383	–	–	0.03%	520
2018 Q2	$398K	Buy	16,383 +4,157	+34%	+$101K	0.03%	493
2018 Q1	$209K	Sell	12,226 -296	-2%	-$5.06K	0.01%	770
2017 Q4	$238K	Sell	12,522 -480	-4%	-$9.12K	0.02%	779
2017 Q3	$229K	Sell	13,002 -461	-3%	-$8.12K	0.02%	780
2017 Q2	$447K	Sell	13,463 -753	-5%	-$25K	0.03%	486
2017 Q1	$456K	Buy	14,216 +3,941	+38%	+$126K	0.03%	466
2016 Q4	$372K	Buy	+10,275	New	+$372K	0.04%	486